Impel Pharmaceuticals (FRA:84P) Days Payable : 146.07 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Impel Pharmaceuticals Days Payable?

Impel Pharmaceuticals's average Accounts Payable for the three months ended in Sep. 2023 was €3.35 Mil. Impel Pharmaceuticals's Cost of Goods Sold for the three months ended in Sep. 2023 was €2.09 Mil. Hence, Impel Pharmaceuticals's Days Payable for the three months ended in Sep. 2023 was 146.07.

The historical rank and industry rank for Impel Pharmaceuticals's Days Payable or its related term are showing as below:

FRA:84P' s Days Payable Range Over the Past 10 Years
Min: 177.26 Med: 1585.52 Max: 2820.96
Current: 177.26

During the past 4 years, Impel Pharmaceuticals's highest Days Payable was 2820.96. The lowest was 177.26. And the median was 1585.52.

FRA:84P's Days Payable is ranked better than
55.19% of 723 companies
in the Biotechnology industry
Industry Median: 148.78 vs FRA:84P: 177.26

Impel Pharmaceuticals's Days Payable declined from Sep. 2022 (278.30) to Sep. 2023 (146.07). It may suggest that Impel Pharmaceuticals accelerated paying its suppliers.

Impel Pharmaceuticals Days Payable Historical Data

The historical data trend for Impel Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impel Pharmaceuticals Days Payable Chart

Impel Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Days Payable

2,742.28

338.92

Impel Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Payable	Get a 7-Day Free Trial											278.30	229.87	245.42	136.94	146.07

Competitive Comparison of Impel Pharmaceuticals's Days Payable

For the Biotechnology subindustry, Impel Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Impel Pharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Impel Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Impel Pharmaceuticals's Days Payable falls into.

Impel Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Impel Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (5.635	+	5.751)	/	2 )	/	6.131	*	365
=	5.693					/	6.131	*	365
=	338.92

Impel Pharmaceuticals's Days Payable for the quarter that ended in Sep. 2023 is calculated as:

	Days Payable (Q: Sep. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (3.192	+	3.499)	/	2 )	/	2.09	*	365 / 4
=	3.3455					/	2.09	*	365 / 4
=	146.07

Impel Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Impel Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Impel Pharmaceuticals (FRA:84P) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Impel Pharmaceuticals Inc (FRA:84P) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

IMPLQ:USA

Address

201 Elliott Avenue West, Suite 260, Seattle, WA, USA, 98119

Website

https://www.impelpharma.com

Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. The company is developing an approach to drug delivery that administers specific formulations of drugs deep into the vascular-rich upper nasal space, a gateway for therapeutic administration of a versatile range of molecules and formulations.

Impel Pharmaceuticals (FRA:84P) Headlines

No Headlines